Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation

NCT: NCT06063148 · ACTIVE_NOT_RECRUITING

NCT IDNCT06063148
StatusACTIVE_NOT_RECRUITING
Start Date2022-04-01
Completion2026-12

Brief Summary

The goal of this clinical trial is to determine if pulse oximeters show an SaO2-SpO2 discrepancy that correlates with skin pigmentation such that pulse oximetry will overestimate oxygenation in newborns with darker skin. The main questions it aims to answer is if SaO2-SpO2 discrepancy varies with the degree of skin pigmentation among neonates, if gestational age has an influence on SaO2-SpO2 discrepancy, and if packed red blood cell (PRBC) transfusion has an influence on SaO2-SpO2 discrepancy in newborns with various degrees of light and dark skin. Researchers will compare SaO2 and SpO2 values in neonates of various skin pigmentation.

Frequently Asked Questions

What is Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation?

Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation is a clinical trial registered under NCT06063148. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06063148?

The current status of NCT06063148 (Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation) is: ACTIVE_NOT_RECRUITING.

When did Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation start?

Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation started on 2022-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.